The enduring problem of overclassification and the challenge of effective declassification are the subject of two public events this week.
The House Committee on Government Oversight and Reform, chaired by Rep. Jason Chaffetz (R-UT), will hold a hearing on Wednesday, December 7 on “examining the costs of overclassification on transparency and security.” The witnesses include former Information Security Oversight Director Bill Leonard, National Security Archive director Tom Blanton, Scott Amey of the Project on Government Oversight, and myself.
The Public Interest Declassification Board, chaired by Prof. Trevor Morrison, will hold a meeting on Thursday, December 8 to discuss potential changes that could be adopted in a future executive order on classification. More information, including advance copies of several presentations to be made at the meeting, can be found here.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.